XERIS PHARMACEUTICALS INC Financing Cash Flow
XERIS PHARMACEUTICALS INC reported Financing Cash Flow of $27.12 million for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2021-08-05
- XERIS PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2021-06-30 was $460.00K, a 99.34% decline year-over-year.
- XERIS PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2021-03-31 was $26.66M, a 33.46% decline year-over-year.
- XERIS PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2020-12-31 was $3.33M, a 68.83% increase year-over-year.
- XERIS PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2020-09-30 was $13.06M, a 42.12% decline year-over-year.
- XERIS PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2020 was $126.06M, a 56.54% increase from fiscal 2019.
- XERIS PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2019 was $80.53M, a 37.19% decline from fiscal 2018.
- XERIS PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2018 was $128.21M, a 264.87% increase from fiscal 2017.
- XERIS PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2017 was $35.14M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2021-06-30 | $460.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $27.12M 10-Q · filed 2021-08-05 | $30.45M derived: sum of 3 quarters · filed 2021-08-05 | $43.51M derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | $26.66M 10-Q · filed 2021-05-13 | $29.99M derived: sum of 2 quarters · filed 2021-05-13 | $43.05M derived: sum of 3 quarters · filed 2021-05-13 | $112.66M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-12-31 | $3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $16.39M derived: sum of 2 quarters · filed 2021-03-09 | $86.00M derived: sum of 3 quarters · filed 2021-08-05 | $126.06M 10-K · filed 2021-03-09 |
| 2020-09-30 | $13.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $82.67M derived: sum of 2 quarters · filed 2021-08-05 | $122.74M 10-Q · filed 2020-11-09 | $124.71M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-06-30 | $69.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $109.67M 10-Q · filed 2021-08-05 | $111.64M derived: sum of 3 quarters · filed 2021-08-05 | $134.22M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $40.07M 10-Q · filed 2021-05-13 | $42.04M derived: sum of 2 quarters · filed 2021-05-13 | $64.61M derived: sum of 3 quarters · filed 2021-05-13 | $64.45M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $24.54M derived: sum of 2 quarters · filed 2021-03-09 | $24.38M derived: sum of 3 quarters · filed 2021-03-09 | $80.53M 10-K · filed 2021-03-09 |
| 2019-09-30 | $22.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $22.41M derived: sum of 2 quarters · filed 2020-11-09 | $78.56M 10-Q · filed 2020-11-09 | $78.59M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | -$157.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $55.99M 10-Q · filed 2020-08-10 | $56.02M derived: sum of 3 quarters · filed 2020-08-10 | $69.20M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $56.15M 10-Q · filed 2020-05-07 | $56.18M derived: sum of 2 quarters · filed 2020-05-07 | $69.36M derived: sum of 3 quarters · filed 2020-05-07 | $160.16M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $13.21M derived: sum of 2 quarters · filed 2020-03-12 | $104.01M derived: sum of 3 quarters · filed 2020-03-12 | $128.21M 10-K · filed 2020-03-12 |
| 2018-09-30 | $13.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $103.98M derived: sum of 2 quarters · filed 2019-11-07 | $128.18M 10-Q · filed 2019-11-07 | $133.65M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $90.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $115.00M 10-Q · filed 2019-08-06 | $120.47M derived: sum of 3 quarters · filed 2019-08-06 | $120.48M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $24.20M 10-Q · filed 2019-05-09 | $29.67M derived: sum of 2 quarters · filed 2019-05-09 | $29.69M derived: sum of 3 quarters · filed 2019-05-09 | |
| 2017-12-31 | $5.47M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $5.49M derived: sum of 2 quarters · filed 2019-03-06 | $35.14M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $29.67M 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $29.65M 10-Q · filed 2018-08-14 |